Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Acq. announced
Appointed director
Quarterly results
|
|
DNIB UNWIND, INC. (BIND)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/30/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on DNIB UNWIND, INC.|
Txns:
| Exercised 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 08/30/2016 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on DNIB UNWIND, INC. |
| 08/30/2016 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on DNIB UNWIND, INC.|
Txns:
| Exercised 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 08/30/2016 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on DNIB UNWIND, INC.|
Txns:
| Exercised 20,000 options to buy
@ $0.44, valued at
$8.8k
|
|
| 08/30/2016 |
4
| LANGER ROBERT (Director) has filed a Form 4 on DNIB UNWIND, INC.|
Txns:
| Exercised 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 06/22/2016 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 06/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2016 |
4
| Rowinsky Eric K (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 06/22/2016 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $0.44, valued at
$8.8k
|
|
| 06/22/2016 |
4
| LANGER ROBERT (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 06/22/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
| 12/16/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2015 |
4
| TROIANO GREGORY (SENIOR VICE PRESIDENT) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 8,000 options to buy
@ $4.36, valued at
$34.9k
|
|
| 10/14/2015 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on BIND Therapeutics, Inc |
| 06/23/2015 |
4
| Hirsch Andrew (PRESIDENT & CEO) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $5.86, valued at
$117.2k
|
|
| 06/10/2015 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| Rowinsky Eric K (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| Nashat Amir (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| LANGER ROBERT (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $5.87, valued at
$88.1k
|
|
| 06/10/2015 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $5.87, valued at
$117.4k
Granted 20,000 options to buy
@ $5.87, valued at
$117.4k
|
|
| 03/10/2015 |
4
| Youssoufian Hagop (CHIEF MEDICAL OFFICER) has filed a Form 4 on BIND Therapeutics, Inc |
| 03/10/2015 |
4
| Lindblom Christopher M (SVP, FINANCE & ADMINISTRATION) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 45,000 options to buy
@ $5.96, valued at
$268.2k
|
|
| 03/10/2015 |
4
| Koerwer Dan (CHIEF BUSINESS OFFICER) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 85,000 options to buy
@ $5.96, valued at
$506.6k
|
|
| 03/10/2015 |
4
| Hirsch Andrew (PRESIDENT & CEO) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 140,000 options to buy
@ $5.96, valued at
$834.4k
|
|
| 11/04/2014 |
4
| Youssoufian Hagop (CHIEF MEDICAL OFFICER) has filed a Form 4 on BIND Therapeutics, Inc |
| 09/12/2014 |
4
| Minick Scott (President & CEO) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Acquired 161 shares
@ $0
Gifted 1,100 shares
@ $0
Acquired 161 shares
@ $0 |
|
| 09/04/2014 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 25,000 options to buy
@ $10.19, valued at
$254.8k
|
|
| 09/04/2014 |
4
| Rowinsky Eric K (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 25,000 options to buy
@ $10.19, valued at
$254.8k
|
|
| 07/09/2014 |
4
| Minick Scott (President & CEO) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Acquired 160 shares
@ $0 |
|
| 05/29/2014 |
4
| Nashat Amir (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $8.73, valued at
$131k
|
|
| 05/29/2014 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $8.73, valued at
$174.6k
|
|
| 05/29/2014 |
4
| LANGER ROBERT (Director) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $8.73, valued at
$131k
|
|
|
|
|